RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsAugust 12, 2024 - WSJ - " J&J, Merck and others are focusing on targets costing $5 billion or less, curtailing pricier acquisitions to help smooth regulators’ approval"
https://www.wsj.com/health/pharma/big-drugmakers-are-clinching-smaller-deals-0c039593